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before transplantation in FAP and non-FAP patients. Mental component improved
in non-FAP (18.47) and worsened in FAP (-7.8) after transplantation. Physical com-
ponent showed improvement in both groups, but significantly greater in non-FAP
group (8.00 versus 16.76). Worst HRQoL scores were associated to limbs pain, dis-
ability, and mental symptoms. LTx must be performed early, before the onset of
somatic symptoms to improve chances of a better HRQoL. CONCLUSIONS: FAP
patients submitted to LTx present worse HRQoL scores when compared to non-FAP
transplanted patients. After LTx, FAP present worse mental component; physical
component showed improvement, but significantly lower than non-FAP group.
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OBJECTIVES: Familial amyloid polyneuropathy (FAP) is an autosomal dominant
disorder, caused by mutant transthyretin protein (TTR). Because most TTR is pro-
duced in hepatocytes, liver transplantation (LTx) has been a treatment option to
prevent long term disease progression. This study aims to report demographic and
clinical characteristics of FAP patients submitted to LTx in Brazil compared to FAP
World Transplant Registry (FAPWTR). METHODS: A literature review was per-
formed by May 2012 through Cochrane Collaboration, Medline, EMBASE, and Lilacs
databases. A retrospective analysis of epidemiological data available from FAPWTR
was developed from 1995 to 2010. RESULTS: From 1995 to 2010, 1,893 LTx were
recorded in 73 centers of 19 countries by FAPWTR. Of these, 5% were performed in
4 Brazilian centers. In FAPWRT cohort, 56% were male, median age at time of
transplantation was 38 years (21-72), and the median disease duration before LTx
was 3 years (0-30). The main causes of death were cardiac complications (22%),
sepsis (22%), liver related complications (14%) and perioperative complications
(3%). The 5-year survival rate was 82%. In a cohort from São Paulo University-Brazil,
24 patients underwent LTx. Patients characteristics were similar to FAPWRT (66.6%
male; median age 36 years), except for disease duration before transplantation
(median: 8 years [2-17]). Six deaths were registered and the main causes were
sepsis and hepatic artery thrombosis. Cardiac related deaths was also observed but
in one case. The overall 5-year survival rate was 58%. Data from 59 Brazilian sub-
jects enrolled in Transthyretin Amyloidosis Outcomes Survey (THAOS) indicated
81% of symptomatic patients and LTx performed in 37.5%. CONCLUSIONS: When
compared to FAPWTR, Brazilian cohort showed longer disease duration before LTx,
and a shorter 5-year survival rate after the procedure. This might be indicative of a
need for better diagnose and management of FAP patients in Brazil.
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OBJECTIVES: Liver transplantation (LTx) is a complex surgical procedure indicated
for patients with serious acute or chronic diseases, when no other effective treat-
ment is available. This retrospective study aims to report temporal trends and
geographic distribution of LTx in Brazil. METHODS: A systematic review was per-
formed by May 2012 to identify publications on LTx in Brazil through Cochrane
Collaboration, Medline, EMBASE, Lilacs databases and gray literature. A retrospec-
tive analysis of epidemiological data available from Brazilian Registry of Trans-
plants (Brazilian Association of Organ Transplants) and Report of Latin American
Transplantation (The Transplantation Society of Latin American and The Carib-
bean) was developed from 1985 to 2011. RESULTS: In Brazil, an increase in LTx
performed annually was observed since the first successful experience (1985). In
2011 1,492 LTx were performed, an increase of 496% over 5 procedures in 1985, with
a survival rate of 74% for patients and 70% for graft. Living donor procedures
showed an increase from 1995 to 2005, but a reduction after 2006 (5 in 1995; 192 in
2005; 104 in 2011). Deceased donor procedures present a continuous growth ten-
dency (3 in 1985; 1,388 in 2011). Nevertheless, in 2009, the waiting list had 4,850
registered patients. Geographic distribution is influenced by transplantation cen-
ters distribution. The distribution of [inhabitants; LTx centers; LTx procedures] in 5
Brazilian geographic region in 2011 is: North [8.09%; 0%; 0%], Northeast [27.97%;
15.79%; 21.24%], Midwest [7.32%; 2.63%; 0%], Southeast [42.20%; 60.53%; 57.92%],
and South [14.43%; 21.05%; 20.84%]. São Paulo state, placed in Southeast region,
represents 31 transplantation centers (76 in Brazil), 21.58% of country population
and 46% of LTx conducted in 2011. CONCLUSIONS: Brazil performed a growing
number of LTx from 1985 to 2011, but this increase may not be enough, once a large
patient’s number remains on waiting lists. Geographical distribution shows to be
significantly irregular in the country.
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OBJECTIVES: Recent recommendations (1) have underscored the need for anemia
assessment and treatment, including iron, prior to scheduled orthopedic surgery.
Administration of intravenous iron alone or combined to erythropoiesis stimulat-
ing agents (ESA) have also been shown to reduce transfusion requirements. How-
ever, the current practices are not well known. The aim of the present study was to
assess the management of iron supplementation and anemia in patients with
scheduled hip or knee surgery. METHODS: A total of 718 Anesthesiologists were
selected from a professional file. Their daily practice on anemia management was
evaluated through a questionnaire. RESULTS: The survey analysis was performed
on 117 questionnaires (return rate: 16%). The most frequent biological exams for
anemia and iron deficiency prescribed by surgeons (45%), anesthesiologist (48%) or
both (7%) before surgery were hemoglobin (100% of questionnaires), ferritin (35%),
serum iron (33%), transferrin and Transferrin saturation (24%). Among the 117
anesthesiologists, 94 (80.3%) declared to prescribe ESA and 104 (89%) iron (oral, 29%;
intravenous, 17%; both, 50%) before surgery. The main reasons to choose intrave-
nous iron were combination to ESA (54%), short delay before surgery (43%), poor
tolerance of oral iron (37%) or poor intestinal absorption (27%); intravenous iron
was also used in the absence of ESA for 37%. In case of anemia after surgery,
intravenous iron given in the first 24 hours was prescribed by 80% of anesthesiol-
ogist. When patient returned home, 65% of survey responders prescribed oral iron.
CONCLUSIONS:This survey shows that optimization of Hemoglobin before surgery
with the use of ESA and iron is wide, but the exploration of anemia is infrequent,
despite recent recommendations. Prospective studies aimed to assess the impact
of intravenous iron alone or combined to ESA before elective orthopedic surgery are
necessary. Prospective studies aimed at better defining the place of iron are still
needed.
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OBJECTIVES: Using information collected from leading Turkish gynecologists, the
costs of different clinical practices of laparoscopic surgery (LS) for endometriosis
treatment were compared. METHODS: Top gynecologists from Turkey were inter-
viewed regarding the best practices to treat endometriosis, including hospitaliza-
tion, tests ordered pre- and post surgery, and the number of follow-up visits per
patient. Physicians’ views were split into two camps with a few opinions in the
middle. The diverging physician opinions were compared and using the physi-
cians’ recommended laparoscopy procedures, the cost of endometriosis treatment
was estimated using Social Security Institution data. RESULTS: The answers re-
garding hospitalization following laparoscopic surgery differed between “hospital-
ization for all patients” and “no hospitalization” after LS. The percentage of pa-
tients recommended for chest radiography and electrocardiogram (ECG) also
varied between 30% and 100%. The number of follow-up visits differed with sug-
gestions for both no and one follow-up visit. Using the interview results and the
assumption that 5% of Turkish women between ages 18 and 49 (N1,000,000) suffer
from endometriosis, the total cost of laparoscopic treatment was estimated for two
sets of recommendations: a) the physician does not hospitalize patients, suggests
chest radiography and ECG for 30% of patients, and does not follow-up with any of
the patients after LS, and b) the physician hospitalizes all patients for one night,
suggests chest radiography and ECG for 100% of patients, and follows-up with all
patients after LS. Depending on physicians’ preference of treatment procedures,
projected costs varied from 200.24, to 241.30. CONCLUSIONS: Different clinical
perspectives and practices of laparoscopic treatment for endometriosis affect cost
of therapy by as much as 41,06 per patient. When combined with the estimated 1
million endometriosis patients in Turkey, total cost differs 41,060,000. Developing
a standard procedure for LS may help lower aggregate costs and cost variation of
procedure.
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OBJECTIVES: Examine the association between degenerative disk disease (DDD)
and patient length of stay (LOS) and total payments among patients who under-
went lumbar fusion surgery. METHODS: Patients who underwent an anterior lum-
bar interbody fusion (ALIF), posterior lumbar fusion (PLF) or transforaminal or pos-
terior lumbar interbody fusion (T/PLIF) surgery over the time period from 2006 -
2009 in the Thomson Reuters MarketScanÒDatabases were identified. These pa-
tients were examined for evidence of degenerative disk disease (DDD). Multivariate
regressions were used to examine the association between DDD and LOS and total
payments, while controlling for patient age, sex, type of insurance coverage, and
type of procedure. RESULTS: Of the 28,647 patients who underwent lumbar fusion
surgery, 7,230 had an ALIF, 16,374 had a PLF, and 5,043 had a T/PLIF. 13,340 (46.57%)
of the sample had a comorbid diagnosis of DDD (ICD-9 code 722.6x, 722.51, 722.52).
However, the majority of these patients were also diagnosed with an additional
comorbid back problem - only 1,911 (6.67%) were diagnosed with stand alone
DDD. Compared to patients without DDD, patients who had DDD and no additional
comorbid back problem were found to have $5,557 lower total payments (P0.0001)
and 0.17 shorter LOS (P0.0001), after controlling for patient characteristics and
type of procedure. In contrast, patients with DDD and an additional comorbid back
diagnoses were found to have $4,876 higher total payments and 0.07 longer LOS
compared to patients without DDD. CONCLUSIONS: DDD is an uncommon sole
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